Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avian Influenza
NanoViricides staff in Vietnam for H5N1/AviFluCide-I trials
May 18th, 2006
NanoViricides, Inc. (NNVC) announced that the entire scientific staff, led by NanoViricides, Inc. President Dr. Anil Diwan, is currently in Vietnam preparing experimental material for the previously announced H5N1/AviFluCide-I trials. They are also meeting with Health Ministry officials to discuss future antirabies trials. "The initial portion of the H5N1/AviFluCide-I trials will take place in in vitro cell culture using the highly pathogenic form of the H5N1 virus," said Diwan. "When data becomes available from the first part of these trials, NanoViricides, Inc. will process the data received, along with the data from the previously reported human...
Source: Biotech Business Week (2006-05-18)
|
